1-10 of 10
Md Kamrul Hasan
Close
Sort by
Journal Articles

Combined Therapy of Zanubrutinib and Zilovertamab in the Inhibition of Invasive Capability of Chronic Lymphocytic Leukemia Cells

Md Kamrul Hasan, George F. Widhopf II, Thomas J. Kipps
Journal: Blood
Blood (2023) 142 (Supplement 1): 6517.
https://doi.org/10.1182/blood-2023-191114
Published: 2023
Journal Articles

Development and Testing of a Glycoengineered Anti-ROR1 Antibody with Enhanced Capacity for Directing Antibody-Dependent Cellular Cytotoxicity (ADCC) of Chronic Lymphocytic Leukemia Cells

Md Kamrul Hasan, George Widhopf II, Christopher Oh, Christina Girgis, Charles E. Prussak, James B. Breitmeyer, Thomas J. Kipps
Journal: Blood
Blood (2023) 142 (Supplement 1): 6836.
https://doi.org/10.1182/blood-2023-187559
Published: 2023
Journal Articles

Wnt5a Induces ROR1-Dependent NFkB Activation to Upregulate MMP9 and Enhance Invasiveness in Chronic Lymphocytic Leukemia

Md Kamrul Hasan, George F. Widhopf II, Thomas J. Kipps
Journal: Blood
Blood (2022) 140 (Supplement 1): 6991.
https://doi.org/10.1182/blood-2022-170209
Published: 2022
Journal Articles

Wnt5a Induces ROR1 to Interact Grb2 to Enhance Ras Activation in Chronic Lymphocytic Leukemia

Md Kamrul Hasan, Laura Z. Rassenti, George F. Widhopf II, Zhouxin Shen, Steven P. Briggs, Thomas J. Kipps
Journal: Blood
Blood (2021) 138 (Supplement 1): 247.
https://doi.org/10.1182/blood-2021-146332
Published: 2021
Journal Articles

Wnt5a Induces ROR1-Dependent Upregulation of MMP9 and Enhanced Invasiveness in Chronic Lymphocytic Leukemia

Md Kamrul Hasan, PhD, Laura Z. Rassenti, PhD, George F. Widhopf II, PhD, Thomas J. Kipps, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4274.
https://doi.org/10.1182/blood-2019-131600
Published: 2019
Journal Articles

Wnt5a induces ROR1 to recruit DOCK2 to activate Rac1/2 in chronic lymphocytic leukemia

Md Kamrul Hasan, Jian Yu, George F. Widhopf, II, Laura Z. Rassenti, Liguang Chen, Zhouxin Shen, Steven P. Briggs, Donna S. Neuberg, Thomas J. Kipps
Journal: Blood
Blood (2018) 132 (2): 170–178.
https://doi.org/10.1182/blood-2017-12-819383
Published: 2018
Includes: Supplemental data
Journal Articles

Wnt5a Induces ROR1 to Complex with DOCK2 and Promote Proliferation of Chronic Lymphocytic Leukemia Cells

Md Kamrul Hasan, PhD, Jian Yu, PhD, George F. Widhopf II, PhD, Laura Z. Rassenti, PhD, Liguang Chen, PhD, Zhouxin Shen, PhD, Steven P. Briggs, PhD, Thomas J. Kipps, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 388.
https://doi.org/10.1182/blood.V130.Suppl_1.388.388
Published: 2017
Journal Articles

Wnt5a Induces ROR1 to Bind and Activate Cortactin, Which Functions in Planar Cell Polarity and Migration of Chronic Lymphocytic Leukemia Cells

Md Kamrul Hasan, PhD, Jian Yu, PhD, George F. Widhopf II, PhD, Laura Z. Rassenti, PhD, Thomas J. Kipps, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 389.
https://doi.org/10.1182/blood.V130.Suppl_1.389.389
Published: 2017
Journal Articles

Durable and Specific Inhibition of ROR1 Signaling Associates with Prolonged Progression Free Survival in Patients with Chronic Lymphocytic Leukemia Treated with Cirmtuzumab

Michael Choi, MD, George F. Widhopf II, PhD, Jian Yu, PhD, Liguang Chen, PhD, Md. Kamrul Hasan, PhD, Laura Z. Rassenti, PhD, Emily Pittman, PhD, Karen Messer, PhD, Charlene Gutierrez, BS, Reilly Lilianna Kidwell, BSc, Charles E. Prussak, PharmD, PhD, Januario E Castro, MD, Catriona Jamieson, MD PhD, Thomas J. Kipps, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 829.
https://doi.org/10.1182/blood.V130.Suppl_1.829.829
Published: 2017
Journal Articles

Wnt5a Induces ROR1 to Complex with HS1, Which Undergoes Tyrosine Phosphorylation and Contributes to Planar-Cell-Polarity Migration in Chronic Lymphocytic Leukemia

Md Kamrul Hasan, PhD, Jian Yu, PhD, Liguang Chen, PhD, Bing Cui, PhD, Zhouxin Shen, PhD, George F. Widhopf, II, PhD, Laura Z. Rassenti, PhD, Steven P. Briggs, PhD, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2016) 128 (22): 301.
https://doi.org/10.1182/blood.V128.22.301.301
Published: 2016